Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...

As previously reported, Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral with a price target of $71, up from $62, citing ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

Cantor Fitzgerald upgraded CVS Health (CVS) to Overweight from Neutral.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...

CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

Shares of CVS Health (NYSE: CVS) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.

CVS CEO David Joyner’s comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry. In addition to its pharmacy retail operations, the company has a ...

Because my dad is no longer here.” “He’s not coming home,” added Jayda. Their father worked as a security guard at CVS on Main Street, where neighbors say crime is a major issue.

But they also have major health benefits, experts say, including antioxidant and anti-inflammatory effects — on top of their high content of fiber, fatty acids, vitamins and minerals.